The preparation, biodistribution, and human’s absorbed dose evaluation of Radio-Scandium-HYNIC-TOC for somatostatin-receptor-positive neuroendocrine tumors therapy by animal study

Deilami-nezhad, Leila; Moghaddam, B.; Sadeghi, Mahdi

doi:10.1097/mnm.0000000000001586

Public

The preparation, biodistribution, and human’s absorbed dose evaluation of Radio-Scandium-HYNIC-TOC for somatostatin-receptor-positive neuroendocrine tumors therapy by animal study

Published in Nuclear Medicine Communications • Jun 6, 2022

Authors:

Leila Deilami-nezhad

B. Moghaddam

Mahdi Sadeghi

Abstract

BACKGROUND: Most of the neuroendocrine tumors (NETs) express Somatostatin receptors (SSTr), which are the main bases for the development of several radiopharmaceuticals for therapy and imaging of these types of tumors. In this study, 46 Scandium nuclide was used to label a peptide compound via hydra...

Subject

Biodistribution

Somatostatin receptor

Somatostatin

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!